ResearcherSecond Military Medical UniversityNo recent work listed

Xin Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7942-3596; OpenAlex author ID A5100348116. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis. Co-author DOI 10.21037/atm-22-556 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chenming Ni · 1 shared paper, 2022 · strength 0.16
- Paper Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR… DOI 10.21037/atm-22-556 ↗
Jun-sheng Ni · 1 shared paper, 2022 · strength 0.16
- Paper Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR… DOI 10.21037/atm-22-556 ↗
Liu Ouyang · 1 shared paper, 2022 · strength 0.16
- Paper Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR… DOI 10.21037/atm-22-556 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.